People with active or suspected cancer: Despite GHK-Cus anti-cancer potential, it theoretically could promote the formation of new blood vessels, which can feed tumors.3 9 14 People with anxiety or mood disorders: Similarly, although GHK-Cu has demonstrated an anxiolytic and anti-aggression effect in rats, the present research is too meager to support it as a viable treatment for anxiety or mood disorders
Metabolism & Elimination The metabolic fate of KLOW Blend involves parallel processing of four distinct peptides [20]: BPC-157: Plasma half-life under 30 minutes but biological effects persist for hours to days TB-500: Estimated 2-3 hour half-life with C-terminal degradation patterns GHK-Cu: Estimated 2-4 hour half-life involving copper release and peptide fragmentation KPV: Estimated 1-2 hour half-life with rapid peptidase degradation to amino acids Complex interactions between components may influence individual clearance rates All components metabolize to amino acids that enter normal metabolic pathways A significant pharmacokinetic paradox exists across all components: despite rapid plasma clearance (30 minutes to 4 hours), biological effects often persist well beyond plasma elimination, suggesting tissue retention, active metabolite formation, persistent signaling cascade activation, or gene expression changes that outlast peptide presence
Compare this complementarity to BPC-157 vs TB-500, where the pairing is angiogenesis plus cell migration
Active B12, also called holotranscobalamin, is the fraction actually delivered to your cells
